Surgeons now have a validated model to identify patients at high risk for early non-curative recurrence after liver resection for hepatocellular carcinoma (HCC), crucial for tailoring postoperative care.

• Early non-curative recurrence significantly increases overall survival risk (hazard ratio 5.39).
• Median survival drops from 178.6 months to just 34.7 months in early recurrence cases (p < 0.001).

Implementing this model can refine patient monitoring and improve long-term outcomes after HCC surgery.

• Key predictive factors include elevated alpha-fetoprotein, larger tumor size, multiple tumors, portal invasion, and serosal invasion.

Using indocyanine green (ICG) fluorescence navigation in laparoscopic hepatectomy leads to better outcomes for hepatic hemangioma patients.

• Median blood loss: 100 ml (ICG) vs 200 ml (conventional), p < 0.001.
• Hospital stays shortened: 5.9 days (ICG) vs 7.1 days (conventional), p < 0.001.

For patients with an Iwate score above 9, ICG significantly reduced operative time (158 min vs 224 min, p < 0.001) and hepatic inflow occlusions.

Consider ICG navigation to enhance surgical precision and patient recovery.

Surgical resection significantly improves survival for hepatocellular carcinoma patients who reach complete response following triple therapy.

• One-, two-, and three-year survival rates post-surgery were 96.0%, 90.8%, and 90.8%, compared to 91.3%, 85.8%, and 73.1% for nonsurgical management.
• Patients who underwent surgery saw 70.9% achieve pathological complete response; however, the overall complication rate was 24.2%.

Surgical resection should be strongly considered for these patients to enhance outcomes.

Surgeons can now better identify patients who may not benefit from surgery for gallbladder cancer.

• 11.1% of patients experienced ‘futile surgery’ with a median survival of only 8.9 months.
• Those who received successful surgical intervention had a median survival of 88.7 months (p < 0.001).

Incorporating this nomogram into preoperative decision-making may significantly reduce unnecessary procedures.

• Key predictors include elevated CA 19-9 levels, borderline resectable status, and the need for extended resections.